ProofPilot and DiMe Partner to Enhance Digital Health in Clinical Trials

ProofPilot has announced a strategic partnership with the Digital Medicine Society (DiMe) to advance digital health in clinical trials, announced in a press release. This collaboration aims to drive the development of innovative digital tools for clinical research, focusing on diverse, accessible, and participant-centered study experiences.

The partnership will utilize ProofPilot's CoPilot platform to enhance study experiences, simplify data collection, and provide streamlined, compliant digital solutions for sites and participants. A key focus of this collaboration is to define and collect physiological signals, behavior traits, and mental health characteristics to train a tool aimed at preventing opioid use disorder (OUD) relapse.

Chris Venezia, CEO of ProofPilot, emphasized the alignment of this partnership with their mission to improve clinical trials through digital innovation. Candice Taguibao, Associate Program Director for DiMe, expressed excitement about working together to implement patient-centered approaches to clinical research and develop a digitally derived tool to help prevent relapse and reduce OUD deaths.